Ofranergene obadenovec
- Generic Name
- Ofranergene obadenovec
- Drug Type
- Biotech
- CAS Number
- 1476737-24-2
- Unique Ingredient Identifier
- 5Q5PRH05GI
Overview
Ofranergene obadenovec is under investigation in clinical trial NCT01229865 (Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer).
Background
Ofranergene obadenovec is under investigation in clinical trial NCT01229865 (Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath